Close Menu

NEW YORK (GenomeWeb) – Applied BioCode announced today that it has received CE mark certification for its BioCode MDx 3000 molecular testing platform and Gastrointestinal Pathogen Panel (GPP).

The BioCode MDx-3000 is a high-volume, automated PCR-based molecular diagnostics platform designed for use by large hospitals and reference labs. The system can process up to 94 samples in about 3.5 hours, or up to 3,384 results in an 8-hour shift, the Santa Fe Springs, California-based firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.